Skip to search formSkip to main contentSkip to account menu

Bone Density Conservation Agents

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat… 
National Institutes of Health

Related topics

Related topics

45 relations

Narrower (35)

24,25-Dihydroxyvitamin D 325-Hydroxyvitamin D 2AlendronateAlfacalcidol
Bone RegenerationFractureIn BloodOsteoporosis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Research Hotspots Analysis of Osteoporosis by PubMed
Objective: To understand the research hotspots of osteoporosis by PubMed. Methods: With MS Excel, SPSS, Cytoscape software, we… 
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Zoledronate].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: ED-71].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Ibandronate].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody].
Review
2007
Review
2007
[New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)